{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:17:18Z","timestamp":1793812638560,"version":"4.6.1"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY19B020008"],"award-info":[{"award-number":["LY19B020008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177105"],"award-info":[{"award-number":["22177105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877101"],"award-info":[{"award-number":["21877101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2018R01015"],"award-info":[{"award-number":["2018R01015"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202410337073"],"award-info":[{"award-number":["202410337073"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117187","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T14:55:20Z","timestamp":1753541720000},"page":"117187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"P1","title":["Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors"],"prefix":"10.1016","volume":"242","author":[{"given":"Ling","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0005","first-page":"822","article-title":"Differential senolytic inhibition of normal versus A\u03b2-associated cholinesterases: implications in aging and Alzheimer's disease","volume":"17","author":"Darvesh","year":"2025","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0010","article-title":"Microglia process \u03b1-synuclein fibrils and enhance their pathogenicity in a TREM2-dependent manner","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv Sci (weinh)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13024-024-00773-1","article-title":"Human VCP mutant ALS\/FTDmicroglia display immune and lysosomal phenotypes independently of GPNMB","volume":"19","author":"Clarke","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.bcp.2025.117187_b0020","article-title":"Microglia and astrocytes in amyotrophic lateral sclerosis: disease-associated states, pathological roles, and therapeutic potential","volume":"12","author":"You","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bcp.2025.117187_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","article-title":"Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)","volume":"108","author":"Hughes","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117187_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2021.787307","article-title":"The colony stimulating factor-1 receptor (CSF-1R)-mediated regulation of microglia\/macrophages as a target for neurological disorders (glioma, stroke)","volume":"12","author":"Barca","year":"2021","journal-title":"Front. Immunol."},{"issue":"6835","key":"10.1016\/j.bcp.2025.117187_b0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/17460441.2014.865012","article-title":"Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer","volume":"9","author":"Z\u00e1mecn\u00edkova","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117187_b0050","doi-asserted-by":"crossref","unstructured":"C.C.L. Chen, S. Deshmukh, S. Jessa, D. Hadjadj, V. Lisi, A.F. Andrade, D. Faury, W. Jawhar, R. Dali, H. Suzuki, M.A.D. Pathania, F. Dubois, E. Woodward, S. H\u00e9bert, M. Coutelier, J. Karamchandani, S. Albrecht, S. Brandner, N. De Jay, , Gayden, T., A. Bajic, A.S. Harutyunyan, D.M. Marchione, L.G. Mikael, N. Juretic, M. Zeinieh, C. Russo, N. Maestro, A.V. Bassenden, P. Hauser, J. Virga, L. Bognar, A. Klekner, M. Zapotocky, A. Vicha, L. Krskova, K. Vanova, J. Zamecnik, D. Sumerauer, P.G. Ekert, D.S. Ziegler, B. Ellezam, M.G. Filbin, M. Blanchette, J.R. Hansford, D.A. Khuong-Quang, A.M. Berghuis, A.G. Weil, B.A. Garcia, L. Garzia, S.C. Mack, R. Beroukhim, K.L. Ligon, M.D. Taylor, P. Bandopadhayay, C. Kramm, S.M. Pfister, A. Korunov, D. Sturm, D.T.W. Jones, P. Salomoni, C.L. Kleinman, N. Jabado, Histone H3.3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis. Cell 183(6) (2020) 1617\u20131633.","DOI":"10.1016\/j.cell.2020.11.012"},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00277-021-04712-8","article-title":"Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement","volume":"101","author":"Di Giacomo","year":"2022","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12017-023-08749-y","article-title":"PDGFRA, KIT, and KDR gene amplification in glioblastoma: heterogeneity and clinical significance","volume":"25","author":"Carlotto","year":"2023","journal-title":"NeuroMol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0092-8674(85)80047-7","article-title":"The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1","volume":"41","author":"Sherr","year":"1985","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bcp.2025.117187_b0070","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tcb.2004.09.016","article-title":"CSF-1 regulation of the wandering macrophage: complexity in action","volume":"14","author":"Pixley","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2025.117187_b0075","unstructured":"P.W. Tipton, D. Kenney-Jung, Rush, K. B. E.H. Middlebrooks, D. Nascene, B. Singh, S. Holtan, E. Ayala, D.F. Broderick, T. Lund, Z.K. Wszolek, Treatment of CSF1R-related leukoencephalopathy: breaking new ground, Mov. Disord., 10."},{"issue":"24","key":"10.1016\/j.bcp.2025.117187_b0080","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.0000000000006642","article-title":"CSF1R-related leukoencephalopathy: a major player in primary microgliopathies","volume":"91","author":"Konno","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2025.117187_b0085","doi-asserted-by":"crossref","unstructured":"M.I. El-Gamal, A.-A. S., D.M. Al-Koumi, M.G. Hamad, N.A. Jalal, C.H. Oh, Recent advances of colony-stimulating factor-1 receptor (CSF-1R) kinase and its inhibitors, J. Med. Chem 2018 Jul 12.","DOI":"10.1021\/acs.jmedchem.7b00873"},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.1209822","article-title":"Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells","volume":"88","author":"Wei","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","article-title":"A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function","volume":"28","author":"Cahoy","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ydbio.2012.03.026","article-title":"The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation","volume":"367","author":"Nandi","year":"2012","journal-title":"Dev. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2025.117187_b0110","doi-asserted-by":"crossref","first-page":"229-+","DOI":"10.1016\/bs.ctdb.2016.10.004","article-title":"Regulation of embryonic and postnatal development by the CSF-1 receptor","volume":"123","author":"Chitu","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117187_b0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1189\/jlb.1105656","article-title":"Dual role of macrophages in tumor growth and angiogenesis","volume":"80","author":"Lamagna","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.bcp.2025.117187_b0130","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1158\/0008-5472.CAN-04-0961","article-title":"Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice","volume":"64","author":"Aharinejad","year":"2004","journal-title":"Can. Res."},{"key":"10.1016\/j.bcp.2025.117187_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01512","article-title":"Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice","volume":"9","author":"Jayasingam","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.bcp.2025.117187_b0140","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"7655","key":"10.1016\/j.bcp.2025.117187_b0145","doi-asserted-by":"crossref","first-page":"495-+","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0150","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-025-57190-1","article-title":"Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12967-025-06276-x","article-title":"IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment","volume":"23","author":"Wu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117187_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107126","article-title":"CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer","volume":"202","author":"Lv","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178146","article-title":"Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages","volume":"10","author":"Sato","year":"2025","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.bcp.2025.117187_b0170","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0175","article-title":"Disruption of GPSM1\/CSF1 signaling reprograms tumor-associated macrophages to overcome anti-PD-1 resistance in colorectal cancer","volume":"13","author":"Chen","year":"2025","journal-title":"J. Immunother. Can."},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/2326-6066.CIR-16-0309","article-title":"Depletion of tumor-associated macrophages with a CSF-1R kinase inhibitor enhances antitumor immunity and survival induced by DC immunotherapy","volume":"5","author":"Dammeijer","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0185","article-title":"Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer","volume":"11","author":"Yu","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.bcp.2025.117187_b0190","first-page":"2","article-title":"Phagocytosis in the brain: homeostasis and disease (vol 10, 790, 2019)","volume":"10","author":"Galloway","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0195","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: from origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2025.117187_b0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume":"94","author":"Subhramanyam","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0205","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"5726","key":"10.1016\/j.bcp.2025.117187_b0210","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0215","doi-asserted-by":"crossref","first-page":"297-+","DOI":"10.1016\/j.neuron.2017.05.037","article-title":"TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss","volume":"95","author":"Paolicelli","year":"2017","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bcp.2025.117187_b0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0896-6273(04)00069-8","article-title":"Microglia promote the death of developing Purkinje cells","volume":"41","author":"Mar\u00edn-Teva","year":"2004","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bcp.2025.117187_b0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/antiox9080743","article-title":"ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2025.117187_b0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnagi.2015.00124","article-title":"Microglial cell dysregulation in brain aging and neurodegeneration","volume":"7","author":"von Bernhardi","year":"2015","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41467-025-56124-1","article-title":"The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions","volume":"16","author":"Martins-Ferreira","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117187_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106817","article-title":"S100A9 protein activates microglia and stimulates phagocytosis, resulting in synaptic and neuronal loss","volume":"206","author":"Pampuscenko","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.bcp.2025.117187_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.028","article-title":"Microglial homeostasis requires balanced CSF-1\/CSF-2 receptor signaling","volume":"30","author":"Chitu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2025.117187_b0250","doi-asserted-by":"crossref","unstructured":"V.G.\u015e. Chitu, S. Nandi, M.F. Mehler, E.R. Stanley, Emerging roles for CSF-1 receptor and its ligands in the nervous system, Trends Neurosci 39(6) (2016) 378\u2013393.","DOI":"10.1016\/j.tins.2016.03.005"},{"issue":"10","key":"10.1016\/j.bcp.2025.117187_b0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.pone.0026317","article-title":"Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits","volume":"6","author":"Erblich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117187_b0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnagi.2021.789834","article-title":"Insights into the role of CSF1R in the central nervous system and neurological disorders","volume":"13","author":"Hu","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2025.117187_b0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.conb.2017.10.004","article-title":"On place and time: microglia in embryonic and perinatal brain development","volume":"47","author":"Thion","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117187_b0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2019.134369","article-title":"The formative role of microglia in stress-induced synaptic deficits and associated behavioral consequences","volume":"711","author":"Bollinger","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"7878","key":"10.1016\/j.bcp.2025.117187_b0275","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2025.117187_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081207","article-title":"The functions and phenotypes of microglia in alzheimer's disease","volume":"12","author":"Fujikawa","year":"2023","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41419-020-2733-4","article-title":"Depletion of microglia exacerbates injury and impairs function recovery after spinal cord injury in mice","volume":"11","author":"Fu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0290","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4103\/1673-5374.357912","article-title":"Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury","volume":"18","author":"Zhou","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bcp.2025.117187_b0295","doi-asserted-by":"crossref","unstructured":"S.K. Wyatt-Johnson, S.A., K.Y. Shim, A.L. Brewster, Suppression of microgliosis with the colony-stimulating factor 1 receptor inhibitor PLX3397 does not attenuate memory defects during epileptogenesis in the rat, Front Neurol. 12 (2021) 651096.","DOI":"10.3389\/fneur.2021.651096"},{"key":"10.1016\/j.bcp.2025.117187_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108565","article-title":"Repurposing of pexidartinib for microglia depletion and renewal","volume":"253","author":"Weyer","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0305","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/s41467-022-31797-0","article-title":"Microglia coordinate cellular interactions during spinal cord repair in mice","volume":"13","author":"Brennan","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-021-02101-6","article-title":"Ceria nanoparticles ameliorate white matter injury after intracerebral hemorrhage: microglia-astrocyte involvement in remyelination","volume":"18","author":"Zheng","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.bcp.2025.117187_b0315","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s11064-021-03516-6","article-title":"The role of ATP receptors in pain signaling","volume":"47","author":"Inoue","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2025.117187_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1265944","article-title":"Mice deficient in complement C3 are protected against recognition memory deficits and astrogliosis induced by status epilepticus","volume":"16","author":"Schartz","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"14","key":"10.1016\/j.bcp.2025.117187_b0325","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1523\/JNEUROSCI.2402-19.2020","article-title":"Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits","volume":"40","author":"Henry","year":"2020","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0330","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1096\/fj.201900567RR","article-title":"Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration","volume":"34","author":"Neal","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2025.117187_b0335","doi-asserted-by":"crossref","unstructured":"Y. Zhu, X. H, Molecular recognition of FDA-approved small molecule protein kinase drugs in protein kinases, Molecules 27(20) (2022) 7124.","DOI":"10.3390\/molecules27207124"},{"key":"10.1016\/j.bcp.2025.117187_b0340","doi-asserted-by":"crossref","unstructured":"M. Walter, L.I., O. Patel, S.E. Broughton, R. Bamert, N.K. Williams, E. Fantino, A.F. Wilks, J. Rossjohn, The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain, J. Mol. Biol. 367(3) (2007) 839\u201347.","DOI":"10.1016\/j.jmb.2007.01.036"},{"issue":"10","key":"10.1016\/j.bcp.2025.117187_b0345","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1021\/acs.jmedchem.3c00428","article-title":"Synthesis and development of highly selective pyrrolo[2,3-d]pyrimidine CSF1R inhibitors targeting the autoinhibited form","volume":"66","author":"Aarhus","year":"2023","journal-title":"J. Med. Chem."},{"issue":"44","key":"10.1016\/j.bcp.2025.117187_b0365","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1073\/pnas.0502000102","article-title":"Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580","volume":"102","author":"Conway","year":"2005","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bmcl.2018.10.051","article-title":"Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking models","volume":"29","author":"Ikegashira","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2025.117187_b0385","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2016.08.019","article-title":"CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus","volume":"185","author":"Chalmers","year":"2017","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0390","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/nau.24896","article-title":"The preventive effects of colony-stimulating factor 1 receptor (CSF-1R) inhibition on bladder outlet obstruction induced remodeling","volume":"41","author":"Wang","year":"2022","journal-title":"Neurourol. Urodyn."},{"issue":"18","key":"10.1016\/j.bcp.2025.117187_b0395","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.7150\/thno.61833","article-title":"Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates","volume":"11","author":"Poulen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2025.117187_b0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2020.106854","article-title":"CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C(+) M2-like macrophage infiltration","volume":"88","author":"Deng","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0405","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.14011","article-title":"Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma","volume":"75","author":"Moon","year":"2020","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.bcp.2025.117187_b0410","doi-asserted-by":"crossref","first-page":"892-+","DOI":"10.1038\/s41563-019-0377-5","article-title":"Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations","volume":"18","author":"Farah","year":"2019","journal-title":"Nat. Mater."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0415","doi-asserted-by":"crossref","DOI":"10.3390\/cells14060414","article-title":"Pharmacological inhibition of microglial proliferation supports blood-brain barrier integrity in experimental autoimmune encephalomyelitis","volume":"14","author":"Borjini","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0420","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/eye.2015.221","article-title":"Light pollution: the possible consequences of excessive illumination on retina","volume":"30","author":"Cont\u00edn","year":"2016","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0425","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-01794-6","article-title":"Intraocular delivery of ZIF-90-RhB-GW2580 nanoparticles prevents the progression of photoreceptor degeneration","volume":"21","author":"Cao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2025.117187_b0430","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.actbio.2023.02.030","article-title":"Red blood cell membrane-camouflaged poly(lactic-co-glycolic acid) microparticles as a potential controlled release drug delivery system for local stellate ganglion microinjection","volume":"161","author":"Liu","year":"2023","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0350","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bmcl.2019.02.006","article-title":"Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952","volume":"29","author":"Ikegashira","year":"2019","journal-title":"Bioorg Med Chem Lett."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0435","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1248\/bpb.b19-00694","article-title":"Pharmacological properties of JTE-952, an orally available and selective colony stimulating factor 1 receptor kinase inhibitor","volume":"43","author":"Uesato","year":"2020","journal-title":"Biol. Pharm. Bull."},{"issue":"12","key":"10.1016\/j.bcp.2025.117187_b0440","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1248\/bpb.b20-00517","article-title":"JTE-952 suppresses bone destruction in collagen-induced arthritis in mice by inhibiting colony stimulating factor 1 receptor","volume":"43","author":"Uesato","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2025.117187_b0445","doi-asserted-by":"crossref","unstructured":"J.S. Smolen, A. D., I.B. McInnes, Rheumatoid arthritis. Lancet 388(10055) (2016) 2023-2038.","DOI":"10.1016\/S0140-6736(16)30173-8"},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0450","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1272\/jnms1923.62.260","article-title":"Macrophage colony-stimulating factor in patients with rheumatoid arthritis","volume":"62","author":"Kawaji","year":"1995","journal-title":"Nihon Ika Daigaku Zasshi"},{"issue":"4","key":"10.1016\/j.bcp.2025.117187_b0455","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.21655","article-title":"Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis - two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.bcp.2025.117187_b0460","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1002\/art.20637","article-title":"Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappa B, osteoprotegerin, and receptor activator of nuclear factor kappa B ligand","volume":"50","author":"Lee","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0465","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00498254.2014.945988","article-title":"Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite","volume":"45","author":"Krauser","year":"2015","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0470","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.2A0114-006R","article-title":"Pleiotropic effects of extended blockade of CSF1R signaling in adult mice","volume":"96","author":"Sauter","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2025.117187_b0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2020.02.011","article-title":"Remodeling tumor immune microenvironment via targeted blockade of PI3K-gamma and CSF-1\/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy","volume":"321","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2025.117187_b0480","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/btm2.10205","article-title":"Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma","volume":"6","author":"Liaw","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"130","key":"10.1016\/j.bcp.2025.117187_b0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"20","key":"10.1016\/j.bcp.2025.117187_b0495","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.7150\/thno.29039","article-title":"Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics","volume":"8","author":"Sharma","year":"2018","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0500","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/btm2.10160","article-title":"Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration","volume":"5","author":"Liaw","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117187_b0505","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.biomaterials.2015.02.053","article-title":"Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers","volume":"52","author":"Zhang","year":"2015","journal-title":"Biomaterials"},{"issue":"14","key":"10.1016\/j.bcp.2025.117187_b0510","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.7150\/thno.57511","article-title":"Magnetism-mediated targeting hyperthermia-immunotherapy in \u201ccold\u201d tumor with CSF1R inhibitor","volume":"11","author":"Fang","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.bcp.2025.117187_b0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijms18050939","article-title":"Magnetic hyperthermia and oxidative damage to DNA of human hepatocarcinoma cells","volume":"18","author":"Cellai","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117187_b0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.8.5.18","article-title":"Magnetic hyperthermia in Y79 retinoblastoma and ARPE-19 retinal epithelial cells: tumor selective apoptotic activity of iron oxide nanoparticle","volume":"8","author":"Demirci","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0525","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41598-024-52003-9","article-title":"Improving tumor treatment through intratumoral injection of drug-loaded magnetic nanoparticles and low-intensity ultrasound","volume":"14","author":"Hosseinpour","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2025.117187_b0530","doi-asserted-by":"crossref","first-page":"14013","DOI":"10.1021\/acsnano.9b06134","article-title":"Enhanced tumor synergistic therapy by injectable magnetic hydrogel mediated generation of hyperthermia and highly toxic reactive oxygen species","volume":"13","author":"Wu","year":"2019","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.bcp.2025.117187_b0535","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1039\/D0BM00713G","article-title":"FXIIIa substrate peptide decorated BLZ945 nanoparticles for specifically remodeling tumor immunity","volume":"8","author":"Wei","year":"2020","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0540","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1039\/C9BM00002J","article-title":"An eximious and affordable GSH stimulus-responsive poly(alpha-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy","volume":"7","author":"Liu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bcp.2025.117187_b0545","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.2147\/IJN.S441131","article-title":"Preparation and characterization evaluation of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)\/combretastatin A4\/BLZ945 nanoparticles for cervical cancer therapy","volume":"18","author":"Guo","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2025.117187_b0550","article-title":"Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)\/combretastatin A4\/BLZ945 nanoparticles on Renca renal carcinoma","volume":"12","author":"Chen","year":"2024","journal-title":"Front Bioeng Biotech"},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0555","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.imbio.2019.03.002","article-title":"Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer","volume":"224","author":"Lu","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.bcp.2025.117187_b0560","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52253","article-title":"Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy","volume":"9","author":"Cui","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0565","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12967-024-06036-3","article-title":"Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117187_b0570","doi-asserted-by":"crossref","unstructured":"V. Dania, N.A. Stavropoulos, P. Gavriil, I. Trikoupis, P. Koulouvaris, O.D. Savvidou, A.F. Mavrogenis, P.J. Papagelopoulos, Treatment modalities for refractory-recurrent tenosynovial giant cell tumor (TGCT): an update. Medicina (Kaunas) 60(10) (2024).","DOI":"10.3390\/medicina60101675"},{"issue":"10197","key":"10.1016\/j.bcp.2025.117187_b0575","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","article-title":"Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial","volume":"394","author":"Tap","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0580","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","article-title":"Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain","volume":"82","author":"Elmore","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.bcp.2025.117187_b0585","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1411366","article-title":"Structure-Guided blockade of CSF1R kinase in tenosynovial giant-cell tumor","volume":"373","author":"Tap","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117187_b0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2025.117187_b0595","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/carcin\/bgac043","article-title":"CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model","volume":"43","author":"Omstead","year":"2022","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0600","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymthe.2018.11.010","article-title":"Modulating the tumor microenvironment via oncolytic viruses and CSF-1R inhibition synergistically enhances anti-PD-1 immunotherapy","volume":"27","author":"Shi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2025.117187_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101884","article-title":"High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer","volume":"51","author":"Lim","year":"2023","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.bcp.2025.117187_b0610","article-title":"A phase 1 study combining pexidartinib, radiation therapy, and androgen deprivation therapy in men with intermediate- and high-risk prostate cancer","volume":"6","author":"Hamid","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0615","article-title":"Phase 1b\/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma","volume":"6","author":"Mendez","year":"2024","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.bcp.2025.117187_b0620","first-page":"11","article-title":"Unravelling the interplay between extracellular acidosis and immune cells","volume":"2018","author":"Diaz","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.bcp.2025.117187_b0625","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1523\/JNEUROSCI.2469-20.2020","article-title":"Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia","volume":"41","author":"Witcher","year":"2021","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0630","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.23926","article-title":"Proton extrusion during oxidative burst in microglia exacerbates pathological acidosis following traumatic brain injury","volume":"69","author":"Ritzel","year":"2021","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0635","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117187_b0640","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac036","article-title":"NRF1-mediated microglial activation triggers high-altitude cerebral edema","volume":"14","author":"Wang","year":"2022","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117187_b0645","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2022.851556","article-title":"PLX5622 reduces disease severity in lethal CNS infection by off-target inhibition of peripheral inflammatory monocyte production","volume":"13","author":"Spiteri","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0650","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI97229","article-title":"Microglia are required for protection against lethal coronavirus encephalitis in mice","volume":"128","author":"Wheeler","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117187_b0655","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2018.09.006","article-title":"Microglia have a protective role in viral encephalitis-induced seizure development and hippocampal damage","volume":"74","author":"Waltl","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117187_b0660","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbi.2022.07.164","article-title":"Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice","volume":"106","author":"Wang","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0360","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2025.117187_b0665","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14398","article-title":"Residual microglia following short-term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy","volume":"24","author":"Kodali","year":"2025","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117187_b0670","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/brain\/aww016","article-title":"Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology","volume":"139","author":"Spangenberg","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117187_b0675","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbi.2023.07.011","article-title":"Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer's disease model by restoring BDNF signaling","volume":"113","author":"Wang","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.bcp.2025.117187_b0680","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12832","article-title":"Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice","volume":"17","author":"Elmore","year":"2018","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.bcp.2025.117187_b0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223918","article-title":"The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis","volume":"14","author":"Manthey","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bcp.2025.117187_b0690","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bcp.2025.117187_b0695","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12974-023-02769-y","article-title":"Pharmacological modulation of TSPO in microglia\/macrophages and neurons in a chronic neurodegenerative model of prion disease","volume":"20","author":"Vicente-Rodr\u00edguez","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bcp.2025.117187_b0375","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1078-0432.CCR-14-1845","article-title":"An open-label, multicenter, phase I\/II Study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma","volume":"21","author":"von Tresckow","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0755","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.3324\/haematol.2014.117028","article-title":"Inhibition of c-Kit by tyrosine kinase inhibitors","volume":"100","author":"Galanis","year":"2015","journal-title":"Haematologica"},{"issue":"33","key":"10.1016\/j.bcp.2025.117187_b0760","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.1002\/anie.201914525","article-title":"New promise and opportunities for allosteric kinase inhibitors","volume":"59","author":"Lu","year":"2020","journal-title":"Angew. Chem.-Int. Edit."},{"issue":"5","key":"10.1016\/j.bcp.2025.117187_b0765","doi-asserted-by":"crossref","first-page":"460","DOI":"10.6026\/973206300200460","article-title":"Decoding the anti-cancer potential of Pexidartinib (PLX3397), a Fms-like tyrosine kinase 3 inhibitor, using next-generation knowledge discovery methods","volume":"20","author":"Alreemi","year":"2024","journal-title":"Bioinformation"},{"issue":"12","key":"10.1016\/j.bcp.2025.117187_b0770","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1158\/1078-0432.CCR-13-2576","article-title":"Sustained inhibition of receptor Tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs","volume":"20","author":"Patwardhan","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117187_b0775","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/1078-0432.CCR-13-3033","article-title":"Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor","volume":"20","author":"Kim","year":"2014","journal-title":"Clin. Can. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117187_b0780","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nn.3318","article-title":"Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways","volume":"16","author":"Kierdorf","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"6005","key":"10.1016\/j.bcp.2025.117187_b0785","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bcp.2025.117187_b0790","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1021\/acs.jmedchem.3c00428","article-title":"Synthesis and development of highly selective pyrrolo[2,3\u2011d]pyrimidine CSF1R inhibitors targeting the autoinhibited form","volume":"66","author":"Aarhus","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117187_b0795","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12974-015-0366-9","article-title":"Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice","volume":"12","author":"Dagher","year":"2015","journal-title":"J. Neuroinflammation"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:29:44Z","timestamp":1761380984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":146,"alternative-id":["S0006295225004526"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117187","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117187"}}